Assessment of the risk factors, depression and quality of life in epileptic patients: a prospective study
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20252112Keywords:
Depression, Epilepsy, Mental health, Polytherapy, Quality of lifeAbstract
Background: Assessing depression and quality of life in epileptic patients is crucial due to epilepsy's neurological and psychological effects. This study examines depression prevalence and severity highlighting the burden on patients and its effect on quality of life, emphasizing the importance of thorough clinical evaluations for effective management.
Methods: A six-month prospective observational study included 120 patients from the inpatient general medicine department. Depression was assessed by patient health questionnaire-9 and quality of life in epilepsy-10 inventory was used to assess quality of life. Statistical analysis was performed using descriptive statistics, the chi-square test, and the Wilcoxon Rank-Sum test.
Results: The severity of depression assessed, revealed that 13.3% experienced minimal, 35.8% had mild, 30% showed moderate, 14.2% had moderately severe, and 6.7% were severe depression. Females exhibited higher depression rates (55.7%) compared to males (44.3%). Highest depression rates were found in patients aged 31-40 (44.3%). Monotherapy was slightly associated with higher depression rates (54.1%) than polytherapy (45.9%). Chi-square analysis indicated a significant association between depression and quality of life (p=0.033*). The Wilcoxon Rank-Sum test showed substantial differences in Epilepsy Effects, Role Functioning, and Mental Health domains between depressed and non-depressed patients, with p-values of 0.019*, 0.017*, and 0.146*, respectively.
Conclusions: The study highlights the need to address depression in epilepsy patients due to its significant impact on mental well-being and overall quality of life. Effective management should consider both neurological and psychological aspects for optimal patient care.
Metrics
References
Fisher RS, Boas W, Blume W, Elger C, Genton P, Lee P, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005;46(4):470-2. DOI: https://doi.org/10.1111/j.0013-9580.2005.66104.x
Tracey AM. Epilepsy: a clinical overview. Am J Med. 2021;134(7):840-7. DOI: https://doi.org/10.1016/j.amjmed.2021.01.038
Hirsch E, French J, Scheffer IE, Bogacz A. ILAE definition of the idiopathic generalized epilepsy syndromes: position statement by the ILAE task force on nosology and definitions. Epilepsia. 2022;63(6):1475-99. DOI: https://doi.org/10.1111/epi.17236
Vera-González A. Pathophysiological mechanisms underlying the etiologies of seizures and epilepsy. In: Czuczwar SJ, editor. Epilepsy. Brisbane: Exon Publications; 2022. DOI: https://doi.org/10.36255/exon-publications-epilepsy-pathopysiology
Hunter SE, Jalazo E, Felton TR, Heinzen EL, Malawsky YS. Epilepsy genetics: advancements in the field and impact on clinical practice. Epilepsy [Internet]. Brisbane (AU): Exon Publications: 2022 Apr 2. Chapter 3. Available from: https://www.ncbi.nlm.nih.gov/books/NBK580613/ DOI: https://doi.org/10.36255/exon-publications-epilepsy-genetics
Epilepsy.com. Landover (MD): Epilepsy Foundation; c1998-2024. Available at: https://www.epilepsy.com/what-is-epilepsy/understanding-seizures/risk-factors. Accessed on 14 October 2024.
Health.com. New York: Dotdash Meredith; c2024. Available at: https://www.health.com/epilepsy-causes-7104317#toc-brain-inflammation. Accessed on 14 October 2024.
Verywell Health. Epilepsy: Causes and Risk Factors. c2023. Available at: https://www.verywellhealth.com/epilepsy-causes-risk-factors-1204427#toc-risk-factors. Accessed on 14 October 2024.
Stafstrom CE, Carmant L. Seizures and epilepsy: an overview for neuroscientists. Cold Spring Harb Perspect Med. 2015;5(6):a022426. DOI: https://doi.org/10.1101/cshperspect.a022426
Ghosh S, Sinha JK, Khan T, Devaraju KS, Singh P, Vaibhav K, Gaur P. Pharmacological and therapeutic approaches in the treatment of epilepsy. Biomedicines. 2021;9(5):470. DOI: https://doi.org/10.3390/biomedicines9050470
Chand PS, Arif H. Depression. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. Available at: https://www.ncbi.nlm.nih.gov/books/NBK430847/. Accessed on 14 October 2024.
Kanner MA. Depression and epilepsy: a new perspective on two closely related disorders. Epilepsy Curr. 2006;6(5):141-6. DOI: https://doi.org/10.1111/j.1535-7511.2006.00125.x
Ayanda KA, Sulyman D. Determinants of quality of life in adults living with epilepsy. Ann Afr Med. 2020;19(3):164-9. DOI: https://doi.org/10.4103/aam.aam_20_18
Sun Y, Fu Z, Bo Q, Mao Z, Ma X, Wang C. The reliability and validity of PHQ-9 in patients with major depressive in psychiatric hospital. BMC Psychiatry. 2020;20:474. DOI: https://doi.org/10.1186/s12888-020-02885-6
Cramer JA, Arrigo C, Van Hammee G, Bromfield EB. Comparison between the QOLIE-31 and derived QOLIE-10 in a clinical trial of levetiracetam. Epilepsy Res. 2000;41(1):29-38. DOI: https://doi.org/10.1016/S0920-1211(00)00127-3
Rashid H, Katyal J, Sood M, Tripati M. Depression in persons with epilepsy: A comparative study of different tools in Indian population. Epilepsy Behav. 2021;115:107633. DOI: https://doi.org/10.1016/j.yebeh.2020.107633
Yang L, Wang Y, Chen X, Zhang C, Chen J, Cheng H, et al. Risk factors for epilepsy: A national cross-sectional study from National Health and Nutrition Examination Survey 2013 to 2018. Int J Gen Med. 2021;14:4405-11. DOI: https://doi.org/10.2147/IJGM.S323209
Jain R, Salunkhe R, Chougule A, Kalwaghe A, Chaudhary B. Depression in adults with epilepsy attending epilepsy clinic in tertiary care hospital: an observational study. Int J Clin Trials. 2022;9(2):50-4. DOI: https://doi.org/10.18203/2349-3259.ijct20220364
Canpolat M, Kumandas S, Poyrazoglu HG, Gumus H, Elmali F, Per H. Prevalence and risk factors of epilepsy among school children in Kayseri city center, an urban area in Central Anatolia, Turkey. Seizure. 2014;23(9):708-16. DOI: https://doi.org/10.1016/j.seizure.2014.05.012
Andrews T, Milinis K, Baker G, Wieshmann U. Self-reported adverse effects of mono and polytherapy for epilepsy. Seizure. 2012;21(8):679-84. DOI: https://doi.org/10.1016/j.seizure.2012.06.013
Baniya GC, Verma K. Prevalence of depression, risk factors, and quality of life in patients with epilepsy in a remote area of western Rajasthan. Epilepsy Behav. 2022;127:108488. DOI: https://doi.org/10.1016/j.yebeh.2021.108488
Mehta S, Tyagi A, Tripathi R, Kumar M. Study of inter-relationship of depression, seizure frequency, and quality of life of people with epilepsy in India. Ment Illn. 2014;6:5169. DOI: https://doi.org/10.4081/mi.2014.5169
Downloads
Published
How to Cite
Issue
Section
